Luca Battistini

17PUBLICATIONS
77CO-AUTHORS
AutoimmunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis.

|Mar 05, 2026
Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.

Lorenzo Tomassini, Teresa Pacifico, Mattia Alberto Serra

|Dec 17, 2025
Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Ilenia Cammarata, Giorgia Sartori, Tiziano Giacomelli

|Aug 28, 2025
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis Treatment.

Monica Margoni, Luca Battistini, Diego Centonze

|Feb 26, 2025
Prevalence and Clinical Correlates of Cerebrovascular Alterations in Fabry Disease: A Cross-Sectional Study.

Daniele Di Natale, Salvatore Rossi, Gianmarco Dalla Zanna

|Jun 26, 2024
Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy.

Peter A Maple, Radu Tanasescu, Cris S Constantinescu

Pageof 3

Frequent Collaborators

6 joint publications

Giovanna Borsellino

5 joint publications

Daniela Francesca Angelini

3 joint publications

Manolo Sambucci

3 joint publications

Marta Pirronello